Summary of Purpose
To assess whether candesartan given to patients with elevated blood pressure in the acute phase of stroke is effective in reducing the risk of death or major disability at 6 months, and the risk of the combined event of vascular death, myocardial infarction, or stroke during the first 6 months.Read More →
The following dates are available for this trial. Trial information last updated on 17 December 2010.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Ullevaal University Hospital, Oslo, Norway. Norwegion authorities. AstraZeneca.
Randomized, placebo-controlled, double-blind, multi-center, international trial.
Else Charlotte Sandset, MD Oslo, Norway E-mail: firstname.lastname@example.org; Fax.: +4722119912; Tel.: +email@example.com